32
Participants
Start Date
July 20, 2019
Primary Completion Date
July 29, 2020
Study Completion Date
May 6, 2022
Metabolic Cofactor Supplementation
Subjects in active treatment will receive dietary supplementation with N-acetylcysteine, L-carnitine tartrate, nicotinamide riboside, and serine, administered as a mixture. Half dosage of the co-factors will be given for two weeks (one dose taken just after dinner), and full dosage for 8 weeks (two equal doses taken just after breakfast and dinner).
Sorbitol
As placebo, sorbitol (5 g) flavored with strawberry aroma and coloring agent will be given. Sorbitol is widely used due to its solubility in water. It's approved by the U.S. Food and Drug Administration (FDA).
Koç University Hospital, Istanbul
Collaborators (1)
Koç University
OTHER
Koç University Hospital
UNKNOWN
Göteborg University
OTHER
Sahlgrenska University Hospital
OTHER
KTH Royal Institute of Technology
OTHER
University of Helsinki
OTHER
Helsinki University Central Hospital
OTHER
Monitor CRO
INDUSTRY
ScandiBio Therapeutics AB
INDUSTRY